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ABSTRACT: An eﬃcient method for the direct construction
of two classes of spirocyclic oxindoles by the reactions of 3-
hydroxyoxindoles/3-aminooxindoles and (Z)-oleﬁnic azlac-
tones through a tandem Michael addition−ring transformation
process has been developed. With DBU as the catalyst, a range
of spiro-butyrolactoneoxindoles and spiro-butyrolactamoxin-
doles, containing an oxygen or a nitrogen heteroatom,
respectively, in the spiro stereocenter, were smoothly obtained with good to excellent diastereoselectivities in high yields.
The spirocyclic oxindole core is represented in some naturaland unnatural compounds possessing important biological
activities.1 It has been shown that a deﬁned spatial arrangement
of the structural element greatly inﬂuences the properties of
those compounds.2 Accordingly, there has been a powerful
inner impetus in organic chemists to develop creative
approaches to access spirocyclic oxindoles, and a lot of
methods for their generation have been designed.3 Potentially
promising skeletons are those containing a heteroatom
(especially N or O) in the spiro stereocenter at the C3
position of the oxindole because of their importance for the
synthesis of medicinally important compounds.4,5 However,
most of the studies have mainly focused on the synthesis of
spirocyclic oxindoles bearing an all-carbon quaternary stereo-
center at the C3 position of the oxindole. In contrast, the
construction of spirocyclic oxindoles bearing a heteroatom at
the C3 position is in need of further development.6 Because of
the correlation between molecular structure and biological
activity,7 it is strongly desired to develop an eﬃcient method
for the construction of spirocyclic oxindoles bearing a
heteroatom at the spiro stereocenter.
We recently demonstrated that 3-aminooxindoles can serve
as nucleophiles for the enantioselective synthesis of quaternary
3-aminooxindoles.8 Some reports have shown that 3-hydrox-
yoxindoles can be used to prepare 3,3-disubstituted oxindole-
s6e−k and that oleﬁnic azlactones can be applied as Michael
acceptors.9 Encouraged by these achievements and on the basis
of our recent successes in preparing diverse spirocyclic
oxindoles,10 we reasoned that two classes of spirocyclic
oxindoles could be constructed through a tandem Michael
addition−ring transformation process involving the reactions of
3-hydroxyoxindoles/3-aminooxindoles and oleﬁnic azlactones
(Scheme 1).11 Herein we report our progress in this area for
preparing spiro-butyrolactoneoxindoles and spiro-butyrolacta-
moxindoles with acceptable results.
To optimize the reaction conditions, 3-hydroxyoxindole 1a
was reacted with (Z)-oleﬁnic azlactone 2a (Table 1). When the
reaction was performed in CH2Cl2 at room temperature with
1 ,4 -d i azab icyc lo[2 .2 .2]octane (DABCO) or 1 ,8 -
diazabicyclo[5.4.0]undec-7-ene (DBU) as the catalyst, spiro-
butyrolactoneoxindole 3a was obtained in a trace amount
(entries 1−2). When the temperature was increased to 40 °C,
3a was obtained in 60% yield with a 67:33:0:0 diastereomeric
ratio (dr) (entry 3). Using 20 mol % DBU at 40 °C for 5 h
aﬀorded 3a in 92% yield with 75:25:0:0 dr (entry 4). The
reactions with other bases showed inferior results in terms of
the yield and dr value compared with DBU as the catalyst
(entries 4−6). Finally, with 20 mol % DBU as the catalyst,
solvent screening revealed CH2Cl2 to be the most selective for
the reaction (entry 4 vs entries 7−10).
With the optimized conditions in hand, we explored the
substrate scope of the reaction of 3-hydroxyoxindoles and (Z)-
oleﬁnic azlactones (Table 2). The steric bulk of the substituent
at N1 in 1a−c had a slight inﬂuence on the diastereoselectivity
but almost no eﬀect on the reactivity (entries 1−3). Substrate
1d incorporating a methyl group at the 5-position of the
oxindole ring was tolerated and provided product 3d with good
results (entry 4). Afterward, we investigated the reactions of 1a
with (Z)-oleﬁnic azlactones 2b−k. It was observed that
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regardless of whether an electron-withdrawing group (2b−e) or
an electron-donating group (2f−h) was used as Ar1 of the
oleﬁnic azlactone, the reactions proceeded well, giving spiro-
butyrolactoneoxindoles 3e−k in up to 93% yield and 83:17:0:0
dr (entries 5−11). 1-Naphthyl-based reactant 2i also gave rise
to the product 3l in 85% yield with 67:33:0:0 dr (entry 12).
Heteroaromatic subject 2j was also successfully employed to
react with 1a, furnishing 3m in excellent yield with 75:25:0:0 dr
(entry 13). The structure and relative conﬁguration of the
product 3m were determined by X-ray analysis.12 A substituent
on the Ar2 group of the oleﬁnic azlactone was well-tolerated
(entry 14). Subsequently, we examined the reaction of oleﬁnic
azlactones 2l−p with 3-hydroxyoxindole 1b (entries 15−19). In
a similar fashion, introduction of an electron-withdrawing or
electron-donating group on Ar2 of the oleﬁnic azlactone did not
aﬀect the reactivity and stereoselectivity (entries 16−19).
The remarkable reactivity between 3-hydroxyoxindoles and
(Z)-oleﬁnic azlactones prompted us to explore another tandem
reaction using 3-aminooxindoles 4 as nucleophiles for the
construction of spiro-butyrolactamoxindoles (Table 3). Diﬀer-
ent substitutions at the N1 position of the 3-aminooxindole
were well-tolerated (entries 1−4, 7, and 8), as were diﬀerent
groups at the N3 position (entries 5 and 6). A series of (Z)-
oleﬁnic azlactones bearing various β-aryl groups were able to
undergo the Michael addition−ring transformation reaction
under the standard conditions, generating spiro-butyrolacta-
moxindoles 5i−p in good yields with excellent diastereose-
lectivities (entries 9−16). Two heteroaromatic azlactones, 2j
and 2r, were also successfully employed in the tandem reaction
(entries 17−19). A bulkier substituent such as naphthyl could
be used to obtaining spiro-butyrolactamoxindole 5t with
excellent results (entry 20). Introduction of a substituent on
the Ar2 group of the oleﬁnic azlactone had no eﬀect on the
stereoselectivity and reactivity (entry 21).
The formyl group incorporated on the butyrolactam ring
could be readily deprotected by hydrolysis with 10% NaOH
solution, leading to compound 6 in 56% yield with >99:1:0:0 dr
(eq 1 in Scheme 2). Nevertheless, we performed an
intermolecular competition experiment between 3-hydroxyox-
indole 1a and 3-aminooxindole 4a by reacting them with 2g
under the standard conditions. The results revealed 3-
hydroxyoxindole to be more reactive and to be preferentially
converted (eq 2 in Scheme 2).
We also tried to develop an enantioselective version of the
tandem Michael addition−ring transformation reaction. We
selected the reaction of 4c and 2a with 10 mol % 6′-OH
cinchona alkaloid A as the catalyst (Scheme 3). The product 5c
was obtained in 47% yield with >99:1:0:0 dr and 61% ee using
xylene as the solvent at room temperature. The absolute
conﬁguration of 5c was not determined at the moment.
In conclusion, we have developed an eﬃcient method for the
direct construction of two classes of spirocyclic oxindoles with
the reaction of 3-hydroxyoxindoles/3-aminooxindoles and (Z)-
oleﬁnic azlactones. The chemistry is based on Michael addition
of the 3-hydroxyoxindole/3-aminooxindole to the (Z)-oleﬁnic
azlactone and sequential ring transformation. With DBU as the
catalyst, the tandem reactions proceeded smoothly and
delivered a wide range of spiro-butyrolactoneoxindoles and
spiro-butyrolactamoxindoles, containing an oxygen heteroatom
or a nitrogen heteroatom, respectively, in the spiro stereo-
center, with very good to excellent diastereoselectivities in high
yields. Additionally, a preliminary trial of an asymmetric version
of the tandem Michael addition−ring transformation process
was conducted, and it aﬀorded the product in moderate yield
with excellent diastereoselectivity and moderate enantioselec-
tivity.
■ EXPERIMENTAL SECTION
General Methods. Reagents were purchased from commercial
sources and were used as received, unless mentioned otherwise.
Reactions were monitored by TLC. 1H NMR and 13C NMR (300 and
75 MHz, respectively) spectra were recorded in CDCl3 and DMSO-d6.
1H NMR chemical shifts are reported in parts per million relative to
tetramethylsilane (TMS) with the solvent resonance employed as the
internal standard (CDCl3 at 7.26 ppm, DMSO-d6 at 2.50 ppm). Data
Scheme 1. Synthetic Strategy for Spiro-Butyrolactoneoxindoles and Spiro-Butyrolactamoxindoles
Table 1. Selected Optimiazation Studiesa
no. catalyst sol. T (°C) t (h) drb yield (%)c
1 DABCO CH2Cl2 25 12 nd trace
2 DBU CH2Cl2 25 12 nd trace
3 DABCO CH2Cl2 40 12 67:33:0:0 60
4 DBU CH2Cl2 40 5 75:25:0:0 92
5 Et3N CH2Cl2 40 8 71:29:0:0 75
6 DMAP CH2Cl2 40 8 50:50:0:0 71
7 DBU CHCl3 40 5 50:50:0:0 87
8 DBU DCEd 40 5 nd trace
9 DBU THF 40 5 67:33:0:0 75
10 DBU toluene 40 8 50:50:0:0 51
aConditions: 1a (0.2 mmol), 2a (0.24 mmol), and 20 mol % catalyst
in 10 mL of solvent. bDetermined by 1H NMR spectroscopy. nd = not
determined. cIsolated yields. dDCE = 1,2-dichloroethane.
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are reported as follows: chemical shift (multiplicity, coupling
constant(s) in Hz, integration). Multiplicities are abbreviated as
follows: s = singlet, br s = broad singlet, d = doublet, t = triplet, q =
quartet, m = multiplet. 13C NMR chemical shifts are reported in parts
per million from tetramethylsilane (TMS) with the solvent resonance
as the internal standard (CDCl3 at 77.20 ppm, DMSO-d6 at 39.51
ppm). Melting points were recorded on a melting point apparatus.
Synthesis of Substrates 4a−d. N-(1-Methyl-2-oxoindolin-3-
yl)formamide (4a). A solution of 3-amino-1-methylindolin-2-one
hydrochloride (2.5 g, 12.6 mmol) in ethyl formate (100 mL) was
heated to reﬂux under an Ar atmosphere, and Et3N (2.1 mL, 15.1
mmol) was added to the resulting mixture. The mixture was reﬂuxed
for 15 h and then concentrated, and the residue was puriﬁed by ﬂash
chromatography (petroleum ether/ethyl acetate = 1:1) to give 4a (1.7
g, 71% yield) as a white solid. Mp 175.8−177.3 °C; 1H NMR (300
MHz, DMSO-d6) δ 3.11 (s, 3H), 5.24 (d, J = 8.1 Hz, 1H), 6.97−7.04
(m, 2H), 7.17 (d, J = 7.2 Hz, 1H), 7.27−7.32 (m, 1H), 8.18 (s, 1H),
Table 2. Scope of 3-Hydroxyoxindoles with Oleﬁnic
Azlactonesa
aSee the Experimental Section for experimental details. bDetermined
by 1H NMR spectroscopy. cIsolated yields. dRun for 8 h. eThe
structure and relative conﬁguration of 3m were determined by single-
crystal X-ray analysis.12
Table 3. Scope of 3-Aminooxindoles with Oleﬁnic
Azlactonesa
aSee the Experimental Section for experimental details. bDetermined
by 1H NMR spectroscopy. cIsolated yields. dThe structure and relative
conﬁguration of the product 5b were determined by X-ray analysis.12
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8.78 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 26.2, 50.6,
108.4, 122.2, 123.4, 126.8, 128.7, 144.0, 161.3, 173.4; HRMS (ESI-
TOF) calcd for C10H10N2NaO2 [M + Na]
+ 213.0634, found 213.0629.
N-(1-Ethyl-2-oxoindolin-3-yl)formamide (4b). The method for the
synthesis of 4b was similar to that for 4a. Product 4b (0.87 g, 91%
yield) was obtained from 3-amino-1-ethylindolin-2-one hydrochloride
(1.0 g, 4.7 mmol) as a white solid. Mp 140.3−141.7 °C; 1H NMR
(300 MHz, DMSO-d6) δ 1.15 (t, J = 7.2 Hz, 3H), 3.70 (q, J = 7.2 Hz,
2H), 5.24 (d, J = 8.1 Hz, 1H), 7.00−7.10 (m, 2H), 7.20 (d, J = 7.2 Hz,
1H), 7.28−7.35 (m, 1H), 8.19 (s, 1H), 8.82 (d, J = 8.1 Hz, 1H); 13C
NMR (75 MHz, DMSO-d6) δ 12.4, 34.2, 50.6, 108.5, 122.0, 123.6,
126.9, 128.7, 143.0, 161.2, 173.0; HRMS (ESI-TOF) calcd for
C11H12N2NaO2 [M + Na]
+ 227.0791, found 227.0789.
N-(2-Oxo-1-phenylindolin-3-yl)formamide (4c). The method for
the synthesis of 4c was similar to that for 4a. Product 4c (0.8 g, 82%
yield) was obtained from 3-amino-1-phenylindolin-2-one hydro-
chloride (1.0 g, 3.8 mmol) as a white solid. Mp 174.3−175.7 °C;
1H NMR (300 MHz, DMSO-d6) δ 5.43 (d, J = 8.1 Hz, 1H), 6.72 (d, J
= 7.8 Hz, 1H), 7.06−7.11 (m, 1H), 7.23−7.30 (m, 2H), 7.41−7.49 (m,
3H), 7.56−7.61 (m, 2H), 8.25 (s, 1H), 8.98 (d, J = 8.1 Hz, 1H); 13C
NMR (75 MHz, DMSO-d6) δ 50.9, 108.8, 122.8, 123.9, 126.6, 126.7,
128.0, 128.7, 129.6, 134.5, 143.8, 161.4, 173.0; HRMS (ESI-TOF)
calcd for C15H12N2NaO2 [M + Na]
+ 275.0791, found 275.0786.
N-(1-Benzyl-2-oxoindolin-3-yl)formamide (4d). The method for
the synthesis of 4d was similar to that for 4a. Product 4d (0.65 g, 67%
yield) was obtained from 3-amino-1-benzylindolin-2-one hydro-
chloride (1.0 g, 3.6 mmol) as a white solid. Mp 139.8−141.2 °C;
1H NMR (300 MHz, DMSO-d6) δ 4.85 (d, J = 15.9 Hz, 1H), 4.96 (d, J
= 15.9 Hz, 1H), 5.37 (d, J = 8.1 Hz, 1H), 6.81 (d, J = 7.8 Hz, 1H),
7.00−7.03 (m, 1H), 7.17−7.42 (m, 7H), 8.23 (s, 1H), 8.98 (d, J = 8.1
Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 42.8, 50.9, 109.0, 122.3,
123.5, 126.8, 127.2, 127.3, 128.5, 129.1, 136.1, 142.9, 161.3, 173.6;
HRMS (ESI-TOF) calcd for C16H14N2NaO2 [M + Na]
+ 289.0947,
found 289.0953.
Synthesis of Substrates 4e and 4f. Ethyl N-(2-Oxo-1-phenyl-
indolin-3-yl)carbamate (4e). To a solution of 3-amino-1-phenyl-
indolin-2-one hydrochloride (1.4 g, 5.4 mmol) in CHCl3 (30 mL) was
added Et3N (1.2 mL, 8.1 mmol) at 0 °C under an Ar atmosphere. The
resulting mixture was vigorously stirred for 15 min, and then ethyl
carbonochloridate (0.6 mL, 5.95 mmol) was slowly added to the
mixture via syringe. The resultant mixture was allowed to stir for 1 h
and then concentrated, and the residue was puriﬁed by ﬂash
chromatography (petroleum ether/ethyl acetate = 2:1) to give 4e
(0.8 g, 50% yield) as a white solid. Mp 181.9−183.2 °C; 1H NMR
(300 MHz, CDCl3) δ 1.25 (s, 3H), 4.17 (q, J = 7.2 Hz, 2H), 5.20 (d, J
= 6.9 Hz, 1H), 5.52 (d, J = 7.5 Hz, 1H), 6.79 (d, J = 7.8 Hz, 1H),
7.08−7.13 (m, 1H), 7.21−7.23 (m, 1H), 7.41−7.44 (m, 4H), 7.50−
7.55 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 14.4, 54.1, 61.6, 109.5,
123.3, 124.6, 126.2, 126.5, 128.2, 129.1, 129.6, 134.3, 143.8, 156.4,
173.8; HRMS (ESI-TOF) calcd for C17H16N2NaO3 [M + Na]
+
319.1053, found 319.1053.
Ethyl N-(1-Benzyl-2-oxoindolin-3-yl)carbamate (4f). The method
for the synthesis of 4f was similar to that for 4e. Product 4f (1.0 g, 63%
yield) was obtained from 3-amino-1-benzylindolin-2-one hydro-
chloride (1.4 g, 5.1 mmol) as a white solid. Mp 125.9−127.4 °C;
1H NMR (300 MHz, CDCl3) δ 1.26 (s, 3H), 4.11−4.19 (m, 2H), 4.86
(d, J = 15.6 Hz, 1H), 4.97 (d, J = 15.6 Hz, 1H), 5.17 (d, J = 6.9 Hz,
1H), 5.37 (d, J = 6.9 Hz, 1H), 6.71 (d, J = 7.8 Hz, 1H), 7.01−7.06 (m,
1H), 7.17−7.22 (m, 1H), 7.27−7.39 (m, 6H); 13C NMR (75 MHz,
CDCl3) δ 14.4, 44.1, 53.9, 61.6, 109.3, 122.9, 124.3, 126.4, 127.3,
127.6, 128.7, 129.1, 135.4, 142.8, 156.4, 174.4; HRMS (ESI-TOF)
calcd for C18H18N2NaO3 [M + Na]
+ 333.1210, found 333.1197.
General Procedure for the Synthesis of Compounds 3. In an
ordinary vial equipped with a magnetic stirring bar, compound 1 (0.2
mmol, 1.0 equiv), compound 2 (0.24 mmol, 1.2 equiv), and catalyst
(DBU, 20 mol %) were dissolved in 10 mL of CH2Cl2, and then the
mixture was reﬂuxed for the indicated time under an Ar atmosphere.
After completion of the reaction as indicated by TLC, the solvent was
removed in vacuo, and the diastereomeric ratio (dr) was determined
by 1H NMR analysis of the crude mixture. The product 3 was isolated
by ﬂash chromatography on silica gel (petroleum ether/ethyl acetate =
10/1−3/1).
N-(1′-Methyl-2′,5-dioxo-3-phenyl-4,5-dihydro-3H-spiro[furan-
2,3′-indolin]-4-yl)benzamide (3a). White solid (75.9 mg, 92% yield),
75:25:0:0 dr (as determined by 1H NMR spectroscopy of the crude
product); mp 215.8−216.9 °C; 1H NMR (300 MHz, DMSO-d6) δ
3.17 (s, 3H), 4.68 (d, J = 13.2 Hz, 1H), 6.10 (dd, J = 8.4 Hz, 13.2 Hz,
1H), 6.91 (d, J = 7.8 Hz, 1H), 7.01−7.14 (m, 6H), 7.23−7.28 (m,
1H), 7.46−7.59 (m, 3H), 7.73 (d, J = 7.5 Hz, 1H), 7.89 (d, J = 7.2 Hz,
2H), 9.32 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 27.0,
50.6, 52.4, 83.5, 109.8, 123.4, 123.9, 125.9, 127.7, 127.8, 128.3, 128.9,
131.4, 132.4, 132.5, 133.3, 143.7, 166.6, 172.2, 172.8; IR (KBr) v 3390,
3064, 2928, 2853, 1786, 1732, 1667, 1617, 1545, 1471, 1377, 1316,
1205, 1096, 1003, 706, 694 cm−1; HRMS (ESI-TOF) calcd for
C25H20N2NaO4 [M + Na]
+ 435.1315, found 435.1303.
N-(1′-Ethyl-2′,5-dioxo-3-phenyl-4,5-dihydro-3H-spiro[furan-2,3′-
indolin]-4-yl)benzamide (3b). White solid (79.3 mg, 93% yield),
50:50:0:0 dr (as determined by 1H NMR spectroscopy of the crude
product); mp 158.1−159.6 °C; 1H NMR (300 MHz, DMSO-d6) δ
(one diastereomer) 0.55 (t, J = 7.2 Hz, 3H), 3.27−3.34 (m, 1H),
3.47−3.54 (m, 1H), 4.57 (d, J = 12.6 Hz, 1H), 5.96 (dd, J = 8.4 Hz,
12.6 Hz, 1H), 6.89−6.91 (m, 2H), 7.03 (d, J = 7.8 Hz, 1H), 7.15−7.20
(m, 3H), 7.29−7.34 (m, 1H), 7.47−7.60 (m, 4H), 7.68 (d, J = 7.2 Hz,
1H), 7.84 (d, J = 7.2 Hz, 2H), 9.17 (d, J = 8.4 Hz, 1H); δ (the other
diastereomer) 1.11 (t, J = 6.9 Hz, 3H), 3.62−3.74 (m, 1H), 3.77−3.84
(m, 1H), 4.67 (d, J = 13.2 Hz, 1H), 6.11 (dd, J = 8.4 Hz, 13.2 Hz, 1H),
6.94 (d, J = 7.8 Hz, 1H), 6.98−7.03 (m, 1H), 7.05−7.15 (m, 4H),
7.22−7.27 (m, 2H), 7.46−7.56 (m, 3H), 7.73 (d, J = 7.2 Hz, 1H), 7.89
(d, J = 7.2 Hz, 2H), 9.33 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ (one diastereomer) 111.6, 34.0, 50.3, 53.3, 83.6, 109.6,
123.7, 124.0, 124.5, 127.2, 127.7, 128.3, 128.5, 128.7, 130.9, 131.9,
132.1, 132.8, 143.1, 166.3, 171.6, 172.9; δ (the other diastereomer)
12.2, 34.7, 50.1, 52.1, 83.0, 109.3, 122.8, 123.7, 125.7, 127.3, 127.5,
127.9, 128.2, 128.3, 128.5, 129.9, 131.0, 131.9, 132.0, 132.8, 142.1,
166.1, 171.4, 172.4; IR (KBr) v 3359, 3062, 2934, 1801, 1728, 1650,
1616, 1531, 1489, 1469, 1375, 1162, 1027, 753, 698 cm−1; HRMS




2,3′-indolin]-4-yl)benzamide (3c). White solid (87.9 mg, 90% yield),
67:33:0:0 dr (as determined by 1H NMR spectroscopy of the crude
product); mp 145.8−147.2 °C; 1H NMR (300 MHz, DMSO-d6) δ
(one diastereomer) 4.48 (d, J = 16.2 Hz, 1H), 4.72 (d, J = 12.6 Hz,
1H), 4.90 (d, J = 16.2 Hz, 1H), 6.06 (dd, J = 8.4 Hz, 12.6 Hz, 1H),
6.48 (d, J = 7.2 Hz, 2H), 6.71 (d, J = 7.5 Hz, 1H), 7.01 (d, J = 7.5 Hz,
2H), 7.07−7.16 (m, 3H), 7.21−7.41 (m, 5H), 7.48−7.60 (m, 3H),
Scheme 2. Transformation of 5m and the Competition
Experiment with 1a and 4a
Scheme 3. Catalytic Enantioselective Variant
The Journal of Organic Chemistry Note
dx.doi.org/10.1021/jo500432c | J. Org. Chem. 2014, 79, 5305−53145308
7.73 (d, J = 7.2 Hz, 1H), 7.84−7.87 (m, 2H), 9.21 (d, J = 8.4 Hz, 1H);
δ (the other diastereomer) 4.73 (d, J = 13.2 Hz, 1H), 4.85 (d, J = 15.9
Hz, 1H), 5.04 (d, J = 15.9 Hz, 1H), 6.11 (dd, J = 8.4 Hz, 13.2 Hz, 1H),
6.85 (d, J = 7.8 Hz, 1H), 6.96−7.10 (m, 5H), 7.20−7.22 (m, 3H),
7.30−7.36 (m, 3H), 7.38−7.41 (m, 1H), 7.48−7.51 (m, 2H), 7.54−
7.56 (m, 1H), 7.80 (d, J = 7.2 Hz, 1H), 7.87−7.90 (m, 2H), 9.34 (d, J
= 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ (one diastereomer)
43.2, 50.9, 53.2, 84.0, 110.7, 124.2, 124.4, 125.1, 126.7, 127.6, 128.5,
128.9, 129.0, 129.2, 131.2, 132.3, 132.5, 133.2, 135.1, 143.8, 166.7,
172.6, 173.2; δ (the other diastereomer) 43.3, 50.5, 52.0, 83.0, 110.0,
123.0, 123.6, 125.9, 127.3, 127.4, 127.6, 127.8, 128.4, 128.5, 128.6,
130.0, 131.0, 131.8, 131.9, 132.8, 135.3, 142.4, 166.1, 171.9, 172.3; IR
(KBr) v 3401, 3061, 2927, 1799, 1707, 1653, 1617, 1512, 1488, 1469,
1382, 1368, 1170, 1023, 753, 702 cm−1; HRMS (ESI-TOF) calcd for
C31H24N2NaO4 [M + Na]
+ 511.1628, found 511.1627.
N-(1′,5′-Dimethyl-2′,5-dioxo-3-phenyl-4,5-dihydro-3H-spiro-
[furan-2,3′-indolin]-4-yl)benzamide (3d). White solid (77.6 mg, 91%
yield), 75:25:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 259.2−260.5 °C; 1H NMR (300 MHz, DMSO-d6)
δ 2.41 (s, 3H), 2.81 (s, 3H), 4.63 (d, J = 12.6 Hz, 1H), 5.90 (dd, J =
8.4 Hz, 12.3 Hz, 1H), 6.88 (d, J = 8.1 Hz, 1H), 6.95−6.97 (m, 2H),
7.19−7.21 (m, 3H), 7.29 (d, J = 8.1 Hz, 1H), 7.47−7.57 (m, 4H),
7.84−7.86 (m, 2H), 9.19 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ 21.1, 26.3, 51.2, 53.1, 84.1, 109.8, 124.3, 125.2, 127.6,
128.0, 128.1, 128.7, 128.9, 129.0, 130.5, 131.7, 132.4, 132.5, 133.2,
133.4, 142.3, 166.7, 172.3, 173.2; IR (KBr) v 3273, 3061, 2926, 1784,
1739, 1644, 1603, 1552, 1499, 1332, 1201, 1111, 999, 697 cm−1;




spiro[furan-2,3′-indolin]-4-yl)benzamide (3e). White solid (80.1 mg,
93% yield), 75:25:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 120.2−121.5 °C; 1H NMR (300 MHz,
DMSO-d6) δ 2.89 (s, 3H), 5.01 (d, J = 12.6 Hz, 1H), 5.93 (dd, J = 8.4
Hz, 12.6 Hz, 1H), 6.97 (d, J = 7.8 Hz, 2H), 7.21−7.29 (m, 3H), 7.45−
7.65 (m, 6H), 7.81−7.84 (m, 2H), 9.19 (d, J = 8.4 Hz, 1H); 13C NMR
(75 MHz, DMSO-d6) δ 26.1, 45.2, 51.1, 83.3, 109.6, 115.5 (d, J = 22.2
Hz, 1C), 118.0 (d, J = 13.7 Hz, 1C), 123.4, 123.7, 124.6 (d, J = 3.5 Hz,
1C), 124.7, 127.2, 128.7, 128.9, 130.6 (d, J = 8.6 Hz, 1C), 132.0 (d, J =
28.1 Hz, 1C), 132.7, 143.9, 161.0 (d, J = 245.8 Hz, 1C), 166.4, 172.1,
172.5; IR (KBr) v 3376, 3063, 2934, 1801, 1728, 1657, 1616, 1530,
1494, 1472, 1380, 1239, 1165, 753, 693 cm−1; HRMS (ESI-TOF)
calcd for C25H19FN2NaO4 [M + Na]
+ 453.1221, found 453.1214.
N-(3-(2-Bromophenyl)-1′-methyl-2′,5-dioxo-4,5-dihydro-3H-
spiro[furan-2,3′-indolin]-4-yl)benzamide (3f). White solid (85.5 mg,
87% yield), 80:20:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 117.9−119.3 °C; 1H NMR (300 MHz,
DMSO-d6) δ 2.94 (s, 3H), 5.39 (d, J = 12.3 Hz, 1H), 5.65 (dd, J = 7.8
Hz, 12.3 Hz, 1H), 6.95 (d, J = 7.8 Hz, 1H), 7.14−7.26 (m, 2H), 7.39−
7.57 (m, 6H), 7.71 (d, J = 7.2 Hz, 2H), 7.81 (d, J = 7.2 Hz, 2H), 9.24
(d, J = 7.8 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 26.1, 50.4, 53.6,
83.8, 109.6, 122.9, 123.3, 126.0, 127.2, 128.0, 128.6, 129.4, 130.5,
130.8, 131.8, 132.1, 132.7, 133.2, 143.8, 166.4, 172.1, 172.5; IR (KBr)
v 3339, 3061, 2925, 1802, 1727, 1654, 1616, 1530, 1491, 1472, 1377,
1241, 1160, 752, 693 cm−1; HRMS (ESI-TOF) calcd for
C25H19BrN2NaO4 [M + Na]
+ 513.0420, found 513.0413.
N-(3-(2,4-Dichlorophenyl)-1′-methyl-2′,5-dioxo-4,5-dihydro-3H-
spiro[furan-2,3′-indolin]-4-yl)benzamide (3g). White solid (79.9 mg,
83% yield), 80:20:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 180.4−181.7 °C; 1H NMR (300 MHz,
DMSO-d6) δ 2.96 (s, 3H), 5.30 (d, J = 12.3 Hz, 1H), 5.72 (dd, J = 8.1
Hz, 12.3 Hz, 1H), 7.00 (d, J = 7.8 Hz, 1H), 7.23−7.28 (m, 1H), 7.43−
7.61 (m, 6H), 7.64−7.70 (m, 2H), 7.80 (d, J = 7.8 Hz, 2H), 9.20 (d, J
= 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 26.6, 48.1, 53.3,
83.8, 110.2, 123.4, 123.9, 125.9, 127.6, 128.1, 128.5, 129.1, 129.6,
131.1, 132.3, 132.6, 133.0, 134.4, 136.2, 144.2, 166.8, 172.3, 172.6; IR
(KBr) v 3381, 3065, 2930, 1801, 1725, 1650, 1616, 1531, 1473, 1378,
1329, 1166, 1009, 752, 694 cm−1; HRMS (ESI-TOF) calcd for
C25H18Cl2N2NaO4 [M + Na]
+ 503.0536, found 503.0531.
N-(3-(4-Cyanophenyl)-1′-methyl-2′,5-dioxo-4,5-dihydro-3H-
spiro[furan-2,3′-indolin]-4-yl)benzamide (3h). White solid (79.6 mg,
91% yield), 50:50:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 256.8−258.2 °C; 1H NMR (300 MHz,
DMSO-d6) δ (one diastereomer) 3.16 (s, 3H), 4.73 (d, J = 12.9 Hz,
1H), 6.14 (dd, J = 8.1 Hz, 12.9 Hz, 1H), 6.92 (d, J = 7.8 Hz, 1H),
6.97−7.03 (m, 1H), 7.24−7.29 (m, 3H), 7.44−7.55 (m, 3H), 7.63 (d, J
= 8.1 Hz, 2H), 7.77 (d, J = 7.5 Hz, 1H), 7.86 (d, J = 7.5 Hz, 2H), 9.34
(d, J = 8.1 Hz, 1H); δ (the other diastereomer) 2.86 (s, 3H), 4.71 (d, J
= 12.3 Hz, 1H), 5.93 (dd, J = 8.1 Hz, 12.3 Hz, 1H), 7.04 (d, J = 7.8
Hz, 1H), 7.13 (d, J = 8.4 Hz, 2H), 7.31−7.36 (m, 1H), 7.46−7.56 (m,
4H), 7.69−7.75 (m, 3H), 7.80−7.85 (m, 2H), 9.22 (d, J = 8.1 Hz,
1H); 13C NMR (75 MHz, DMSO-d6) δ (one diastereomer) 27.0, 50.6,
52.4, 83.1, 109.9, 111.2, 118.6, 123.4, 123.5, 126.0, 127.8, 128.9, 129.0,
131.7, 132.5, 132.8, 133.1, 138.4, 143.6, 166.6, 171.9, 172.3; δ (the
other diastereomer) 26.0, 50.6, 52.6, 83.2, 109.8, 111.3, 118.2, 123.3,
124.0, 124.4, 127.1, 127.3, 128.6, 128.7, 132.1, 132.4, 132.7, 136.9,
144.1, 166.3, 171.6, 172.2; IR (KBr) v 3369, 3062, 2935, 1801, 1725,
1658, 1616, 1531, 1491, 1471, 1377, 1311, 1243, 1161, 1007, 754, 694




2,3′-indolin]-4-yl)benzamide (3i). White solid (77.6 mg, 91% yield),
80:20:0:0 dr (as determined by 1H NMR spectroscopy of the crude
product); mp 105.8−107.3 °C; 1H NMR (300 MHz, DMSO-d6) δ
2.15 (s, 3H), 2.86 (s, 3H), 4.56 (d, J = 12.6 Hz, 1H), 5.94 (dd, J = 8.4
Hz, 12.6 Hz, 1H), 6.84 (d, J = 8.1 Hz, 2H), 6.98−7.01 (m, 3H), 7.29−
7.34 (m, 1H), 7.47−7.57 (m, 4H), 7.66 (d, J = 7.2 Hz, 1H), 7.82−7.85
(m, 2H), 9.15 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ
20.9, 26.4, 51.3, 53.1, 84.0, 110.1, 124.2, 124.3, 124.7, 127.6, 128.0,
128.4, 129.0, 129.5, 132.2, 132.5, 133.2, 138.0, 144.7, 166.7, 172.5,
173.3; IR (KBr) v 3377, 3056, 2931, 1806, 1732, 1650, 1616, 1516,
1494, 1470, 1343, 1256, 1164, 978, 754, 696 cm−1; HRMS (ESI-TOF)
calcd for C26H22N2NaO4 [M + Na]
+ 449.1472, found 449.1472.
N-(3-(4-Methoxyphenyl)-1′-methyl-2′,5-dioxo-4,5-dihydro-3H-
spiro[furan-2,3′-indolin]-4-yl)benzamide (3j). White solid (77.9 mg,
88% yield), 83:17:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 285.6−287.1 °C; 1H NMR (300 MHz,
DMSO-d6) δ 3.16 (s, 3H), 3.57 (s, 3H), 4.59 (d, J = 13.2 Hz, 1H),
6.04 (dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.69 (d, J = 8.7 Hz, 2H), 6.91−7.01
(m, 3H), 7.05 (d, J = 7.5 Hz, 1H), 7.25−7.30 (m, 1H), 7.45−7.58 (m,
3H), 7.74 (d, J = 7.2 Hz, 1H), 7.87−7.89 (m, 2H), 9.28 (d, J = 8.4 Hz,
1H); 13C NMR (75 MHz, DMSO-d6) δ 26.5, 50.5, 51.5, 54.9, 83.2,
109.4, 113.9, 123.0, 123.6, 123.7, 125.5, 127.3, 128.5, 128.7, 131.0,
132.0, 132.9, 143.3, 158.6, 166.1, 171.8, 172.5; IR (KBr) v 3383, 3068,
2936, 1806, 1725, 1635, 1616, 1533, 1517, 1492, 1472, 1380, 1259,
1150, 1026, 830, 719 cm−1; HRMS (ESI-TOF) calcd for
C26H22N2NaO5 [M + Na]
+ 465.1421, found 465.1402.
N-(3-(Benzo[d][1,3]dioxol-5-yl)-1′-methyl-2′,5-dioxo-4,5-dihydro-
3H-spiro[furan-2,3′-indolin]-4-yl)benzamide (3k). White solid (83.1
mg, 91% yield), 75:25:0:0 dr (as determined by 1H NMR spectroscopy
of the crude product); mp 242.8−244.2 °C; 1H NMR (300 MHz,
DMSO-d6) δ 3.16 (s, 3H), 4.58 (d, J = 13.2 Hz, 1H), 5.86 (s, 2H),
5.99 (dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.48 (d, J = 8.1 Hz, 1H), 6.68 (d, J
= 6.6 Hz, 2H), 6.95 (d, J = 7.8 Hz, 1H), 7.03−7.08 (m, 1H), 7.28−
7.33 (m, 1H), 7.46−7.59 (m, 3H), 7.78 (d, J = 7.5 Hz, 1H), 7.89 (d, J
= 7.2 Hz, 2H), 9.29 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-
d6) δ 26.6, 50.7, 51.7, 83.1, 101.1, 107.5, 108.3, 109.5, 121.4, 123.0,
123.6, 125.7, 127.4, 128.5, 131.1, 132.0, 132.8, 143.3, 146.7, 147.3,
166.2, 171.8, 172.3; IR (KBr) v 3290, 3065, 2895, 1798, 1724, 1664,
1615, 1541, 1493, 1471, 1376, 1245, 1160, 936, 758 cm−1; HRMS




spiro[furan-2,3′-indolin]-4-yl) benzamide (3l). White solid (78.6 mg,
85% yield), 67:33:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 255.6−257.1 °C; 1H NMR (300 MHz,
DMSO-d6) δ (one diastereomer) 2.76 (s, 3H), 5.65 (d, J = 12.6 Hz,
1H), 6.06 (dd, J = 8.4 Hz, 12.3 Hz, 1H), 6.71 (d, J = 6.9 Hz, 1H),
7.18−7.35 (m, 4H), 7.41−7.62 (m, 5H), 7.75−7.87 (m, 6H), 9.13 (d, J
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= 8.1 Hz, 1H); δ (the other diastereomer) 2.85 (s, 3H), 5.51 (d, J =
12.9 Hz, 1H), 6.37 (dd, J = 8.1 Hz, 12.9 Hz, 1H), 6.65 (d, J = 7.8 Hz,
1H), 6.95−7.00 (m, 1H), 7.10−7.15 (m, 1H), 7.28−7.37 (m, 2H),
7.41−7.46 (m, 2H), 7.49−7.54 (m, 1H), 7.64−7.74 (m, 3H), 7.77−
7.93 (m, 5H), 9.33 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-
d6) δ (one diastereomer) 25.9, 46.9, 52.7, 84.2, 109.6, 122.3, 123.5,
123.7, 124.7, 125.2, 125.4, 125.6, 125.9, 126.9, 127.1, 128.6, 129.0,
131.7, 132.0, 132.1, 132.7, 133.2, 143.9, 166.4, 172.5, 172.8; δ (the
other diastereomer) 26.3, 47.2, 51.1, 83.1, 109.1, 122.4, 122.7, 123.6,
124.8, 125.7, 125.9, 126.1, 126.6, 127.3, 128.0, 128.1, 128.4, 128.7,
130.7, 131.8, 131.9, 132.8, 133.0, 142.8, 166.2, 172.4, 172.6; IR (KBr)
v 3367, 3058, 2929, 1801, 1716, 1671, 1616, 1526, 1492, 1471, 1379,
1325, 1163, 1011, 778, 693 cm−1; HRMS (ESI-TOF) calcd for
C29H22N2NaO4 [M + Na]
+ 485.1472, found 485.1471.
N-(1′-Methyl-2′,5-dioxo-3-(thiophen-2-yl)-4,5-dihydro-3H-spiro-
[furan-2,3′-indolin]-4-yl)benzamide (3m). White solid (79.5 mg, 95%
yield), 75:25:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 134.3−135.8 °C; 1H NMR (300 MHz, DMSO-d6)
δ 2.96 (s, 3H), 4.80 (d, J = 12.3 Hz, 1H), 5.78 (dd, J = 8.4 Hz, 12.3
Hz, 1H), 6.88−6.92 (m, 2H), 7.10 (d, J = 7.8 Hz, 1H), 7.31−7.36 (m,
2H), 7.52−7.61 (m, 5H), 7.85−7.88 (m, 2H), 9.25 (d, J = 8.4 Hz,
1H); 13C NMR (75 MHz, DMSO-d6) δ 26.1, 48.7, 52.6, 83.0, 109.9,
123.3, 123.9, 124.4, 126.4, 126.6, 127.0, 127.2, 128.7, 132.2, 132.8,
133.8, 144.7, 166.4, 171.8, 172.2; IR (KBr) v 3360, 3062, 2928, 1802,
1727, 1651, 1616, 1530, 1491, 1471, 1383, 1244, 1162, 1004, 753, 709




spiro[furan-2,3′-indolin]-4-yl) benzamide (3n). White solid (80.1 mg,
93% yield), 75:25:0:0 dr (as determined by 1H NMR spectroscopy of
the crude product); mp 138.4−139.8 °C; 1H NMR (300 MHz,
DMSO-d6) δ 3.15 (s, 3H), 4.64 (d, J = 13.2 Hz, 1H), 6.08 (dd, J = 8.1
Hz, 13.2 Hz, 1H), 6.89 (d, J = 7.8 Hz, 1H), 6.97−7.15 (m, 6H), 7.22−
7.27 (m, 1H), 7.38−7.44 (m, 1H), 7.48−7.57 (m, 1H), 7.67 (d, J = 9.6
Hz, 1H), 7.74 (d, J = 7.5 Hz, 2H), 9.41 (d, J = 8.1 Hz, 1H); 13C NMR
(75 MHz, DMSO-d6) δ 26.6, 50.4, 51.9, 83.2, 109.4, 114.2 (d, J = 22.9
Hz, 1C), 119.0 (d, J = 20.9 Hz, 1C), 123.0, 123.5, 123.6 (d, J = 2.6 Hz,
1C), 125.7, 127.4, 127.9, 128.5, 130.8 (d, J = 8.0 Hz, 1C), 131.0, 132.0,
135.1 (d, J = 6.8 Hz, 1C), 143.3, 162.0 (d, J = 243.2 Hz, 1C), 164.9,
171.8, 172.3; IR (KBr) v 3282, 3069, 2928, 1797, 1727, 1663, 1615,
1536, 1486, 1471, 1376, 1331, 1152, 1003, 802, 749 cm−1; HRMS




[furan-2,3′-indolin]-4-yl)benzamide (3o). White solid (82.0 mg, 89%
yield), 80:20:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 252.2−253.7 °C; 1H NMR (300 MHz, DMSO-d6)
δ 1.11 (t, J = 6.9 Hz, 3H), 3.66−3.82 (m, 2H), 4.64 (d, J = 13.2 Hz,
1H), 6.09 (dd, J = 8.1 Hz, 13.2 Hz, 1H), 6.97−7.11 (m, 4H), 7.21−
7.28 (m, 3H), 7.46−7.57 (m, 3H), 7.78 (d, J = 7.5 Hz, 1H), 7.88 (d, J
= 7.2 Hz, 2H), 9.33 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-
d6) δ 12.6, 35.2, 50.6, 52.1, 83.2, 109.9, 123.3, 123.9, 126.2, 127.8,
128.8, 128.9, 129.9, 131.5, 131.6, 132.4, 133.0, 133.2, 142.5, 166.6,
171.7, 172.6; IR (KBr) v 3357, 3057, 2927, 1797, 1717, 1667, 1618,
1520, 1489, 1469, 1384, 1334, 1162, 1021, 752, 725 cm−1; HRMS




[furan-2,3′-indolin]-4-yl)benzamide (3p). White solid (92.0 mg, 91%
yield), 80:20:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 117.9−119.4 °C; 1H NMR (300 MHz, DMSO-d6)
δ 0.55 (t, J = 7.2 Hz, 3H), 3.29−3.33 (m, 1H), 3.47−3.54 (m, 1H),
4.55 (d, J = 12.6 Hz, 1H), 5.95 (dd, J = 8.4 Hz, 12.6 Hz, 1H), 6.88−
6.91 (m, 2H), 7.02 (d, J = 7.8 Hz, 1H), 7.16−7.20 (m, 3H), 7.29−7.34
(m, 1H), 7.47−7.52 (m, 1H), 7.67 (d, J = 6.9 Hz, 1H), 7.72 (d, J = 8.7
Hz, 2H), 7.79 (d, J = 8.7 Hz, 2H), 9.27 (d, J = 8.4 Hz, 1H); 13C NMR
(75 MHz, DMSO-d6) δ 12.0, 34.3, 50.7, 53.7, 84.0, 110.0, 124.1, 124.3,
124.9, 126.3, 128.1, 128.7, 128.9, 129.7, 131.2, 132.1, 132.3, 143.5,
165.8, 171.9, 173.2; IR (KBr) v 3350, 3062, 2935, 1801, 1725, 1664,
1616, 1533, 1484, 1469, 1375, 1211, 1162, 1012, 752, 699 cm−1;




indolin]-4-yl)-2-methylbenzamide (3q). White solid (81.1 mg, 92%
yield), 67:33:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 115.6−117.1 °C; 1H NMR (300 MHz, DMSO-d6)
δ 0.57 (t, J = 6.9 Hz, 3H), 2.24 (s, 3H), 3.26−3.33 (m, 1H), 3.46−3.55
(m, 1H), 4.50 (d, J = 12.6 Hz, 1H), 5.93 (dd, J = 8.7 Hz, 12.6 Hz, 1H),
6.90−6.92 (m, 2H), 7.03 (d, J = 7.8 Hz, 1H), 7.19−7.34 (m, 8H),
7.46−7.51 (m, 1H), 7.64 (d, J = 7.2 Hz, 1H), 8.86 (d, J = 8.4 Hz, 1H);
13C NMR (75 MHz, DMSO-d6) δ 12.0, 19.6, 34.4, 50.4, 53.7, 83.9,
110.0, 124.1, 124.4, 124.9, 126.1, 127.2, 128.0, 128.8, 128.9, 130.4,
131.2, 131.3, 132.3, 135.8, 135.9, 143.5, 169.7, 171.9, 173.2; IR (KBr)
v 3347, 3063, 2924, 1766, 1712, 1670, 1614, 1532, 1489, 1468, 1383,
1316, 1190, 730, 698 cm−1; HRMS (ESI-TOF) calcd for
C27H24N2NaO4 [M + Na]
+ 463.1628, found 463.1617.
N-(1′-Ethyl-2′,5-dioxo-3-phenyl-4,5-dihydro-3H-spiro[furan-2,3′-
indolin]-4-yl)-4-methylbenzamide (3r). White solid (79.3 mg, 90%
yield), 75:25:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 117.2−118.6 °C; 1H NMR (300 MHz, DMSO-d6)
δ 0.55 (t, J = 6.9 Hz, 3H), 2.34 (s, 3H), 3.28−3.33 (m, 1H), 3.47−3.54
(m, 1H), 4.57 (d, J = 12.6 Hz, 1H), 5.96 (dd, J = 8.4 Hz, 12.6 Hz, 1H),
6.89−6.91 (m, 2H), 7.02 (d, J = 7.8 Hz, 1H), 7.18−7.20 (m, 3H),
7.28−7.34 (m, 3H), 7.47−7.49 (m, 1H), 7.67 (d, J = 6.6 Hz, 1H), 7.75
(d, J = 8.1 Hz, 2H), 9.08 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ 12.0, 21.4, 34.3, 50.6, 53.7, 84.0, 110.0, 124.1, 124.5,
124.9, 127.6, 128.1, 128.7, 128.8, 129.5, 130.5, 131.3, 132.2, 142.5,
143.5, 166.6, 172.0, 173.4; IR (KBr) v 3371, 3061, 2931, 1801, 1724,
1648, 1614, 1535, 1490, 1469, 1375, 1211, 1161, 1018, 751, 699 cm−1;




indolin]-4-yl)-4-methoxybenzamide (3s). White solid (85.8 mg, 94%
yield), 67:33:0:0 dr (as determined by 1H NMR spectroscopy of the
crude product); mp 108.4−109.8 °C; 1H NMR (300 MHz, DMSO-d6)
δ 1.09 (t, J = 6.9 Hz, 3H), 3.61−3.68 (m, 1H), 3.76−3.83 (m, 4H),
4.64 (d, J = 13.2 Hz, 1H), 6.06 (dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.91−
7.11 (m, 9H), 7.20−7.25 (m, 1H), 7.69 (d, J = 7.5 Hz, 1H), 7.85 (d, J
= 8.7 Hz, 2H), 9.14 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-
d6) δ 12.2, 34.7, 50.0, 52.2, 55.5, 83.0, 109.4, 113.7, 122.8, 123.8, 125.1,
125.7, 127.5, 127.9, 128.4, 129.3, 131.0, 132.1, 142.2, 162.1, 165.7,
171.4, 172.6; IR (KBr) v 3354, 3066, 2919, 1797, 1718, 1660, 1605,
1528, 1508, 1471, 1330, 1257, 1175, 1025, 850, 798, 699 cm−1; HRMS
(ESI-TOF) calcd for C27H24N2NaO5 [M + Na]
+ 479.1577, found
479.1576.
General Procedure for the Synthesis of Compounds 5. In an
ordinary vial equipped with a magnetic stirring bar, compound 4 (0.15
mmol, 1.0 equiv), compound 2 (0.18 mmol, 1.2 equiv), and catalyst
(DBU, 20 mol %) were dissolved in 10 mL of CH2Cl2, and then the
mixture was reﬂuxed for the indicated time. After completion of the
reaction as indicated by TLC, the reaction mixture was directly
puriﬁed by ﬂash chromatography (petroleum ether/ethyl acetate = 10/
1−2/1) on silica gel to yield the product 5.
N-(1′-Formyl-1-methyl-2,5′-dioxo-3′-phenylspiro[indoline-3,2′-
pyrrolidin]-4′-yl)benzamide (5a). White solid (61.3 mg, 93% yield),
>99:1:0:0 dr; mp 278.5−279.8 °C; 1H NMR (300 MHz, DMSO-d6) δ
3.13 (s, 3H), 4.37 (d, J = 13.2 Hz, 1H), 6.02 (dd, J = 8.4 Hz, 12.9 Hz,
1H), 6.79 (d, J = 7.8 Hz, 1H), 6.95−6.99 (m, 3H), 7.04−7.14 (m,
4H), 7.44−7.55 (m, 3H), 7.66 (d, J = 7.2 Hz, 1H), 7.86 (d, J = 7.2 Hz,
2H), 9.08 (s, 1H), 9.24 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ 26.5, 51.9, 52.2, 65.7, 108.5, 122.4, 124.0, 124.5, 127.3,
127.9, 128.1, 128.5, 129.7, 131.7, 132.0, 132.9, 143.2, 159.1, 166.2,
172.6, 172.7; IR (KBr) v 3362, 3061, 2925, 1765, 1713, 1665, 1615,
1536, 1492, 1472, 1382, 1341, 1253, 1096, 752, 697 cm−1; HRMS




rolidin]-4′-yl)benzamide (5b). White solid (62.6 mg, 92% yield),
92:8:0:0 dr; mp 268.5−269.7 °C; 1H NMR (300 MHz, DMSO-d6) δ
1.08 (t, J = 6.9 Hz, 3H), 3.64−3.78 (m, 2H), 4.38 (d, J = 13.2 Hz, 1H),
The Journal of Organic Chemistry Note
dx.doi.org/10.1021/jo500432c | J. Org. Chem. 2014, 79, 5305−53145310
6.03 (dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.82 (d, J = 7.8 Hz, 1H), 6.94−7.14
(m, 7H), 7.46−7.55 (m, 3H), 7.67 (d, J = 7.2 Hz, 1H), 7.87 (d, J = 7.2
Hz, 2H), 9.08 (s, 1H), 9.25 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ 12.0, 34.6, 52.0, 52.2, 65.6, 108.6, 122.2, 124.2, 124.8,
127.4, 127.9, 128.0, 128.1, 128.5, 129.7, 131.6, 132.0, 132.9, 142.2,
159.1, 166.2, 172.3, 172.7; IR (KBr) v 3377, 3062, 2931, 1763, 1705,
1666, 1615, 1530, 1490, 1469, 1379, 1338, 1316, 1286, 1097, 713, 698




din]-4′-yl)benzamide (5c). White solid (67.7 mg, 90% yield),
>99:1:0:0 dr; mp 296.2−297.6 °C; 1H NMR (300 MHz, DMSO-d6)
δ 4.47 (d, J = 12.9 Hz, 1H), 6.11 (dd, J = 8.4 Hz, 12.9 Hz, 1H), 6.40
(d, J = 7.8 Hz, 1H), 6.99−7.15 (m, 7H), 7.24 (d, J = 7.8 Hz, 2H),
7.43−7.54 (m, 4H), 7.57−7.63 (m, 2H), 7.76 (d, J = 7.2 Hz, 1H), 7.86
(d, J = 7.8 Hz, 2H), 9.16 (s, 1H), 9.29 (d, J = 8.4 Hz, 1H); 13C NMR
(75 MHz, DMSO-d6) δ 52.2, 52.3, 65.9, 108.9, 123.1, 123.8, 125.2,
126.4, 127.4, 128.0, 128.1, 128.2, 128.5, 128.6, 128.7, 129.9, 130.0,
131.7, 132.1, 132.9, 133.8, 143.1, 159.4, 166.3, 172.4, 172.5; IR (KBr)
v 3351, 3062, 2924, 1769, 1708, 1667, 1614, 1533, 1500, 1467, 1378,
1317, 1259, 1026, 755, 700 cm−1; HRMS (ESI-TOF) calcd for
C31H23N3NaO4 [M + Na]
+ 524.1581, found 524.1583.
N-(1-Benzyl-1′-formyl-2,5′-dioxo-3′-phenylspiro[indoline-3,2′-
pyrrolidin]-4′-yl)benzamide (5d). White solid (72.7 mg, 94% yield),
>99:1:0:0 dr; mp 231.2−232.7 °C; 1H NMR (300 MHz, DMSO-d6) δ
4.45 (d, J = 13.2 Hz, 1H), 4.86 (d, J = 15.9 Hz, 1H), 4.97 (d, J = 15.9
Hz, 1H), 6.04 (dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.62 (d, J = 7.8 Hz, 1H),
6.92−7.06 (m, 7H), 7.24−7.29 (m, 5H), 7.44−7.55 (m, 3H), 7.73 (d, J
= 7.2 Hz, 1H), 7.87 (d, J = 7.2 Hz, 2H), 9.14 (s, 1H), 9.27 (d, J = 8.4
Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 43.4, 52.2, 52.6, 65.8,
109.3, 122.5, 124.1, 124.9, 127.4, 127.5, 128.0, 128.1, 128.4, 128.5,
128.6, 129.7, 131.5, 132.0, 132.9, 135.6, 142.5, 159.3, 166.3, 172.6,
172.9; IR (KBr) v 3369, 3062, 2926, 1801, 1728, 1649, 1615, 1532,
1489, 1469, 1383, 1330, 1181, 1163, 998, 752, 698 cm−1; HRMS (ESI-
TOF) calcd for C32H25N3NaO4 [M + Na]
+ 538.1737, found 538.1756.
Ethyl 4′-Benzamido-2,5′-dioxo-1,3′-diphenylspiro[indoline-3,2′-
pyrrolidine]-1′-carboxylate (5e). White solid (71.2 mg, 87% yield),
95:5:0:0 dr; mp 196.8−198.3 °C; 1H NMR (300 MHz, DMSO-d6) δ
1.05 (t, J = 6.9 Hz, 3H), 4.13 (q, J = 6.9 Hz, 2H), 4.38 (d, J = 13.2 Hz,
1H), 5.99 (dd, J = 8.7 Hz, 13.2 Hz, 1H), 6.42 (d, J = 7.2 Hz, 1H),
7.02−7.14 (m, 7H), 7.22 (d, J = 7.8 Hz, 2H), 7.44−7.54 (m, 4H),
7.58−7.63 (m, 2H), 7.78 (d, J = 7.2 Hz, 1H), 7.85 (d, J = 7.8 Hz, 2H),
9.18 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 13.9, 52.1,
55.0, 63.2, 68.1, 108.8, 123.1, 124.5, 125.0, 126.2, 127.3, 128.0, 128.2,
128.5, 129.8, 130.0, 131.7, 131.9, 133.0, 133.8, 142.7, 149.8, 166.2,
169.7, 173.2; IR (KBr) v 3386, 3060, 2925, 1806, 1731, 1668, 1613,
1529, 1501, 1374, 1337, 1316, 1268, 1218, 1039, 751, 699 cm−1;




3,2′-pyrrolidine]-1′- carboxylate (5f). White solid (77.2 mg, 92%
yield), >99:1:0:0 dr; mp 85.8−87.4 °C; 1H NMR (300 MHz, DMSO-
d6) δ 0.96 (t, J = 6.9 Hz, 3H), 3.95−4.05 (m, 2H), 4.33 (d, J = 13.2
Hz, 1H), 4.78 (d, J = 15.9 Hz, 1H), 4.89 (d, J = 15.9 Hz, 1H), 5.88
(dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.64 (d, J = 7.8 Hz, 1H), 6.91−7.08 (m,
7H), 7.17−7.28 (m, 5H), 7.44−7.50 (m, 3H), 7.70 (d, J = 7.2 Hz,
1H), 7.82 (d, J = 7.2 Hz, 2H), 9.13 (d, J = 8.4 Hz, 1H); 13C NMR (75
MHz, DMSO-d6) δ 13.7, 43.5, 51.8, 52.6, 63.0, 68.0, 109.2, 122.5,
124.2, 125.3, 127.3, 127.5, 128.0, 128.4, 128.5, 129.7, 131.6, 131.9,
133.0, 135.6, 142.4, 149.6, 166.2, 169.8, 173.8; IR (KBr) v 3332, 3062,
2927, 1764, 1730, 1708, 1676, 1616, 1544, 1488, 1469, 1369, 1298,
1260, 1183, 1032, 749, 700 cm−1; HRMS (ESI-TOF) calcd for
C34H29N3NaO5 [M + Na]
+ 582.1999, found 582.2022.
N-(3′-(2,4-Dichlorophenyl)-1′-formyl-1-methyl-2,5′-dioxospiro-
[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5g). White solid (68.6
mg, 90% yield), >99:1:0:0 dr; mp 333.8−335.2 °C; 1H NMR (300
MHz, DMSO-d6) δ 3.08 (s, 3H), 4.81 (d, J = 12.6 Hz, 1H), 6.09 (dd, J
= 8.4 Hz, 12.3 Hz, 1H), 6.85 (d, J = 7.8 Hz, 1H), 6.92−6.97 (m, 1H),
7.15−7.20 (m, 2H), 7.39−7.58 (m, 5H), 7.83−7.85 (m, 3H), 9.10 (s,
1H), 9.32 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 26.6,
47.4, 53.5, 64.9, 108.5, 122.0, 123.9, 125.2, 126.5, 127.4, 128.5, 128.7,
129.5, 129.9, 132.0, 132.2, 132.8, 133.1, 135.3, 143.3, 159.2, 166.2,
172.1, 172.6; IR (KBr) v 3333, 3061, 2933, 1764, 1717, 1662, 1615,
1532, 1492, 1472, 1381, 1337, 1297, 1254, 755, 695 cm−1; HRMS




[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5h). White solid (73.6
mg, 86% yield), 96:4:0:0 dr; mp 278.2−279.7 °C; 1H NMR (300
MHz, DMSO-d6) δ 4.95 (d, J = 12.6 Hz, 1H), 6.19 (dd, J = 8.1 Hz,
12.3 Hz, 1H), 6.49 (d, J = 7.8 Hz, 1H), 6.99−7.04 (m, 1H), 7.10−7.15
(m, 1H), 7.24−7.29 (m, 3H), 7.45−7.63 (m, 8H), 7.85 (d, J = 7.2 Hz,
2H), 7.96 (d, J = 7.2 Hz, 1H), 9.18 (s, 1H), 9.37 (d, J = 8.1 Hz, 1H);
13C NMR (75 MHz, DMSO-d6) δ 47.5, 53.7, 65.2, 108.9, 122.7, 123.7,
125.9, 126.3, 126.7, 127.4, 128.6, 128.8, 129.4, 129.9, 130.0, 132.1,
132.3, 132.8, 133.4, 134.0, 135.4, 143.2, 159.5, 166.2, 172.0, 172.2; IR
(KBr) v 3351, 3061, 2923, 1771, 1727, 1705, 1668, 1615, 1516, 1483,
1466, 1331, 1303, 1223, 756, 702 cm−1; HRMS (ESI-TOF) calcd for
C31H21Cl2N3NaO4 [M + Na]
+ 592.0801, found 592.0817.
N-(1-Benzyl-3′-(2-ﬂuorophenyl)-1′-formyl-2,5′-dioxospiro-
[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5i). White solid (72.8 mg,
91% yield), >99:1:0:0 dr; mp 218.3−219.5 °C; 1H NMR (300 MHz,
DMSO-d6) δ 4.76 (d, J = 12.9 Hz, 1H), 4.83 (d, J = 16.2 Hz, 1H), 4.94
(d, J = 16.2 Hz, 1H), 6.11 (dd, J = 8.4 Hz, 12.9 Hz, 1H), 6.56 (d, J =
7.8 Hz, 1H), 6.90−6.97 (m, 3H), 7.01−7.13 (m, 2H), 7.22−7.33 (m,
6H), 7.45−7.58 (m, 3H), 7.78 (d, J = 7.5 Hz, 1H), 7.86−7.88 (m,
2H), 9.15 (s, 1H), 9.31 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ 43.3, 45.0, 52.4, 65.3, 109.2, 115.1 (d, J = 21.9 Hz, 1C),
119.0 (d, J = 14.3 Hz, 1C), 122.3, 123.9, 125.1, 127.0, 127.4, 128.4,
128.6, 129.8, 130.0, 130.1, 132.1, 132.8, 135.6, 142.6, 159.3, 161.1 (d, J
= 244.6 Hz, 1C), 166.2, 172.3, 172.7; IR (KBr) v 3387, 3067, 2921,
1765, 1719, 1661, 1614, 1519, 1489, 1468, 1338, 1309, 1257, 754, 697




[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5j). White solid (71.8 mg,
87% yield), 94:6:0:0 dr; mp 190.2−191.7 °C; 1H NMR (300 MHz,
DMSO-d6) δ 4.40 (d, J = 12.9 Hz, 1H), 4.87 (d, J = 15.9 Hz, 1H), 4.97
(d, J = 15.9 Hz, 1H), 6.00 (dd, J = 8.4 Hz, 12.9 Hz, 1H), 6.68 (d, J =
7.8 Hz, 1H), 6.95−7.00 (m, 3H), 7.08−7.13 (m, 3H), 7.24−7.29 (m,
5H), 7.45−7.50 (m, 2H), 7.53−7.58 (m, 1H), 7.77 (d, J = 7.2 Hz,
1H), 7.86 (d, J = 7.2 Hz, 2H), 9.14 (s, 1H), 9.26 (d, J = 8.1 Hz, 1H);
13C NMR (75 MHz, DMSO-d6) δ 43.3, 51.7, 52.7, 65.6, 109.4, 122.6,
123.8, 124.9, 127.3, 127.4, 127.5, 128.1, 128.5, 128.6, 129.9, 130.2,
130.6, 132.1, 132.7, 132.8, 135.6, 142.3, 159.3, 166.3, 172.3, 172.7; IR
(KBr) v 3367, 3067, 2931, 1765, 1719, 1665, 1618, 1535, 1489, 1471,
1378, 1339, 1298, 1253, 753, 697 cm−1; HRMS (ESI-TOF) calcd for
C32H24ClN3NaO4 [M + Na]
+ 572.1348, found 572.1361.
N-(1-Benzyl-3′-(4-cyanophenyl)-1′-formyl-2,5′-dioxospiro-
[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5k). White solid (74.6
mg, 92% yield), 94:6:0:0 dr; mp 192.3−193.7 °C; 1H NMR (300
MHz, DMSO-d6) δ 4.49 (d, J = 12.9 Hz, 1H), 4.85 (d, J = 15.9 Hz,
1H), 5.00 (J = 15.9 Hz, 1H), 6.08 (dd, J = 8.1 Hz, 12.9 Hz, 1H), 6.69
(d, J = 7.8 Hz, 1H), 6.94−6.99 (m, 1H), 7.06−7.13 (m, 1H), 7.17 (d, J
= 8.4 Hz, 2H), 7.28−7.31 (m, 5H), 7.45−7.58 (m, 5H), 7.80 (d, J =
7.2 Hz, 1H), 7.84−7.87 (m, 2H), 9.15 (s, 1H), 9.30 (d, J = 8.1 Hz,
1H); 13C NMR (75 MHz, DMSO-d6) δ 43.4, 52.1, 52.5, 65.5, 109.4,
110.8, 118.2, 122.7, 123.5, 125.0, 127.4, 127.5, 127.6, 128.5, 128.6,
129.4, 130.0, 131.9, 132.1, 132.7, 135.6, 137.4, 142.2, 159.3, 166.3,
172.1, 172.5; IR (KBr) v 3262, 3063, 2925, 1769, 1722, 1698, 1652,
1614, 1540, 1489, 1468, 1334, 1309, 1252, 1029, 751, 700 cm−1;




[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5l). White solid (70.2 mg,
88% yield), >99:1:0:0 dr; mp 171.2−172.7 °C; 1H NMR (300 MHz,
DMSO-d6) δ 3.59 (s, 3H), 4.46 (d, J = 12.9 Hz, 1H), 6.10 (dd, J = 8.4
Hz, 12.9 Hz, 1H), 6.46 (d, J = 7.8 Hz, 1H), 6.66−6.70 (m, 3H), 7.00−
7.04 (m, 1H), 7.06−7.13 (m, 2H), 7.26 (d, J = 7.5 Hz, 2H), 7.48−7.62
(m, 6H), 7.79 (d, J = 7.2 Hz, 1H), 7.89 (d, J = 7.2 Hz, 2H), 9.17 (s,
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1H), 9.31 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 52.2,
52.3, 55.0, 65.8, 108.9, 113.5, 113.6, 120.4, 123.0, 123.8, 125.2, 126.4,
127.4, 128.6, 128.7, 129.4, 129.9, 130.0, 132.1, 132.9, 133.3, 133.9,
143.1, 158.9, 159.4, 166.3, 172.4; IR (KBr) v 3375, 3061, 2922, 1765,
1715, 1702, 1664, 1613, 1528, 1499, 1466, 1377, 1330, 1294, 1261,
1028, 751, 699 cm−1; HRMS (ESI-TOF) calcd for C32H25N3NaO5 [M
+ Na]+ 554.1686, found 554.1667.
N-(1′-Formyl-3′-(4-methoxyphenyl)-2,5′-dioxo-1-phenylspiro-
[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5m). White solid (68.6
mg, 86% yield), 96:4:0:0 dr; mp 264.3−265.8 °C; 1H NMR (300
MHz, DMSO-d6) δ 3.60 (s, 3H), 4.39 (d, J = 13.2 Hz, 1H), 6.04 (dd, J
= 8.4 Hz, 13.2 Hz, 1H), 6.46 (d, J = 7.8 Hz, 1H), 6.72 (d, J = 8.7 Hz,
2H), 7.00−7.06 (m, 3H), 7.09−7.14 (m, 1H), 7.26 (d, J = 7.5 Hz,
2H), 7.45−7.56 (m, 4H), 7.59−7.64 (m, 2H), 7.77 (d, J = 7.2 Hz,
1H), 7.87 (d, J = 7.2 Hz, 2H), 9.15 (s, 1H), 9.25 (d, J = 8.4 Hz, 1H);
13C NMR (75 MHz, DMSO-d6) δ 51.8, 52.4, 55.0, 65.9, 108.9, 113.6,
123.1, 123.3, 124.0, 125.1, 126.5, 127.4, 128.6, 128.7, 129.2, 129.9,
130.0, 132.0, 132.9, 133.9, 143.1, 158.8, 159.4, 166.2, 172.5; IR (KBr)
v 3371, 3063, 2928, 1769, 1712, 1660, 1614, 1517, 1501, 1467, 1315,
1256, 1231, 1028, 754, 700 cm−1; HRMS (ESI-TOF) calcd for
C32H25N3NaO5 [M + Na]
+ 554.1686, found 554.1670.
N-(1-Benzyl-1′-formyl-2,5′-dioxo-3′-(p-tolyl)spiro[indoline-3,2′-
pyrrolidin]-4′-yl)benzamide (5n). White solid (71.5 mg, 90% yield),
>99:1:0:0 dr; mp 199.8−201.2 °C; 1H NMR (300 MHz, DMSO-d6) δ
2.07 (s, 3H), 4.36 (d, J = 13.2 Hz, 1H), 4.84 (d, J = 15.9 Hz, 1H), 4.94
(d, J = 15.9 Hz, 1H), 5.97 (dd, J = 8.4 Hz, 13.2 Hz, 1H), 6.61 (d, J =
7.8 Hz, 1H), 6.81−6.87 (m, 4H), 6.92−6.97 (m, 1H), 7.04−7.09 (m,
1H), 7.20−7.29 (m, 5H), 7.43−7.56 (m, 3H), 7.71 (d, J = 7.2 Hz,
1H), 7.84 (d, J = 7.2 Hz, 2H), 9.11 (s, 1H), 9.21 (d, J = 8.4 Hz, 1H);
13C NMR (75 MHz, DMSO-d6) δ 20.9, 43.6, 52.3, 53.1, 66.1, 109.7,
122.8, 124.5, 125.1, 127.6, 127.7, 127.8, 128.6, 128.8, 128.9, 129.0,
130.1, 132.3, 133.2, 135.9, 137.5, 142.8, 159.6, 166.5, 173.0, 173.2; IR
(KBr) v 3270, 3063, 2925, 1762, 1719, 1704, 1655, 1615, 1548, 1487,
1333, 1319, 1308, 1250, 1026, 752, 700 cm−1; HRMS (ESI-TOF)
calcd for C33H27N3NaO4 [M + Na]
+ 552.1894, found 552.1899.
N-(1-Benzyl-1′-formyl-3′-(4-methoxyphenyl)-2,5′-dioxospiro-
[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5o). White solid (72.8
mg, 89% yield), >99:1:0:0 dr; mp 87.2−88.7 °C; 1H NMR (300 MHz,
DMSO-d6) δ 3.57 (s, 3H), 4.36 (d, J = 13.2 Hz, 1H), 4.87 (d, J = 16.2
Hz, 1H), 4.94 (d, J = 16.2 Hz, 1H), 5.96 (dd, J = 8.4 Hz, 12.9 Hz, 1H),
6.57 (d, J = 8.4 Hz, 2H), 6.66 (d, J = 7.8 Hz, 1H), 6.89 (d, J = 8.4 Hz,
2H), 6.95−7.00 (m, 1H), 7.07−7.13 (m, 1H), 7.28−7.32 (m, 5H),
7.45−7.58 (m, 3H), 7.73 (d, J = 7.2 Hz, 1H), 7.86 (d, J = 7.5 Hz, 2H),
9.13 (s, 1H), 9.23 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-
d6) δ 43.3, 51.8, 52.9, 54.9, 65.8, 109.3, 113.4, 122.5, 123.1, 124.2,
124.8, 127.4, 127.5, 128.5, 128.6, 129.6, 129.7, 132.0, 132.9, 135.6,
142.5, 158.7, 159.3, 166.2, 172.6, 172.9; IR (KBr) v 3337, 3062, 2930,
1762, 1714, 1668, 1614, 1534, 1516, 1468, 1340, 1313, 1252, 1181,
1026, 700 cm−1; HRMS (ESI-TOF) calcd for C33H27N3NaO5 [M +
Na]+ 568.1843, found 568.1838.
N-(3′-(Benzo[d][1,3]dioxol-5-yl)-1-benzyl-1′-formyl-2,5′-
dioxospiro[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5p). White
solid (73.0 mg, 87% yield), >99:1:0:0 dr; mp 213.5−214.9 °C; 1H
NMR (300 MHz, DMSO-d6) δ 4.33 (d, J = 13.2 Hz, 1H), 4.87 (d, J =
16.2 Hz, 1H), 4.93 (d, J = 16.2 Hz, 1H), 5.84−5.94 (m, 3H), 6.41 (d, J
= 8.1 Hz, 1H), 6.55−6.58 (m, 2H), 6.65 (d, J = 7.8 Hz, 1H), 6.95−
7.00 (m, 1H), 7.09−7.14 (m, 1H), 7.27−7.30 (m, 5H), 7.44−7.56 (m,
3H), 7.75 (d, J = 7.2 Hz, 1H), 7.86 (d, J = 7.2 Hz, 2H), 9.10 (s, 1H),
9.23 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 43.4, 52.0,
53.1, 65.8, 101.1, 107.9, 108.2, 109.4, 122.5, 124.1, 124.9, 125.2, 127.2,
127.4, 127.5, 128.5, 128.6, 129.8, 132.0, 132.9, 135.6, 142.5, 146.8,
146.9, 159.3, 166.2, 172.4, 172.9; IR (KBr) v 3330, 3064, 2925, 1761,
1719, 1702, 1658, 1615, 1504, 1490, 1335, 1307, 1243, 1040, 753, 700




3,2′-pyrrolidine]-4′-yl)benzamide (5q). White solid (58.6 mg, 85%
yield), 92:8:0:0 dr; mp 223.5−234.9 °C; 1H NMR (300 MHz, DMSO-
d6) δ 1.14 (t, J = 6.9 Hz, 3H), 3.75 (q, J = 6.9 Hz, 2H), 4.59 (d, J =
12.9 Hz, 1H), 5.78 (dd, J = 8.4 Hz, 12.9 Hz, 1H), 6.75−6.77 (m, 1H),
6.80 (s, 1H), 6.94−7.02 (m, 2H), 7.22−7.24 (m, 2H), 7.47−7.57 (m,
3H), 7.63 (d, J = 7.2 Hz, 1H), 7.88 (d, J = 6.9 Hz, 2H), 9.06 (s, 1H),
9.28 (d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 12.0, 34.7,
47.6, 54.5, 65.4, 108.8, 122.3, 124.0, 124.9, 126.3, 126.6, 126.8, 127.3,
128.4, 128.6, 130.1, 132.0, 132.9, 134.5, 142.8, 159.1, 166.3, 171.8,
171.9; IR (KBr) v 3326, 3063, 2926, 1771, 1718, 1703, 1675, 1616,
1540, 1492, 1469, 1297, 1263, 1026, 755, 697 cm−1; HRMS (ESI-




[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5r). White solid (68.8 mg,
88% yield), >99:1:0:0 dr; mp 275.6−277.1 °C; 1H NMR (300 MHz,
DMSO-d6) δ 4.65 (d, J = 12.9 Hz, 1H), 4.85 (d, J = 16.2 Hz, 1H), 5.02
(d, J = 16.2 Hz, 1H), 5.73 (dd, J = 8.4 Hz, 12.6 Hz, 1H), 6.67−6.75
(m, 3H), 6.97−7.02 (m, 1H), 7.13−7.28 (m, 7H), 7.46−7.58 (m, 3H),
7.71 (d, J = 7.2 Hz, 1H), 7.87 (d, J = 7.2 Hz, 2H), 9.12 (s, 1H), 9.30
(d, J = 8.1 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 43.4, 48.1, 55.1,
65.5, 109.5, 122.7, 123.9, 125.0, 126.6, 127.1, 127.4, 127.5, 128.5,
128.6, 130.1, 132.1, 132.9, 134.3, 135.5, 142.9, 159.3, 166.3, 171.7,
172.5; IR (KBr) v 3310, 3064, 2923, 1770, 1718, 1702, 1672, 1614,
1541, 1489, 1468, 1298, 1265, 1025, 719, 699 cm−1; HRMS (ESI-




3,2′-pyrrolidin]-4′-yl)benzamide (5s). White solid (60.5 mg, 82%
yield), 94:6:0:0 dr; mp 175.6−177.2 °C; 1H NMR (300 MHz, DMSO-
d6) δ 4.47 (d, J = 12.6 Hz, 1H), 5.86 (dd, J = 8.4 Hz, 12.6 Hz, 1H),
6.18 (s, 1H), 6.29 (d, J = 3.0 Hz, 1H), 6.59 (d, J = 7.8 Hz, 1H), 6.98−
7.03 (m, 1H), 7.15−7.20 (m, 1H), 7.38−7.41 (m, 3H), 7.49−7.59 (m,
4H), 7.62−7.67 (m, 3H), 7.91 (d, J = 7.2 Hz, 2H), 9.14 (s, 1H), 9.39
(d, J = 8.4 Hz, 1H); 13C NMR (75 MHz, DMSO-d6) δ 46.4, 52.3, 64.6,
108.5, 108.9, 110.4, 123.0, 123.6, 125.1, 126.6, 127.4, 128.7, 130.0,
132.1, 132.9, 134.1, 143.4, 143.6, 147.9, 159.5, 166.4, 171.8, 172.1; IR
(KBr) v 3356, 3063, 2928, 1773, 1716, 1668, 1616, 1545, 1491, 1465,
1292, 1268, 1026, 755, 697 cm−1; HRMS (ESI-TOF) calcd for
C29H21N3NaO5 [M + Na]
+ 514.1373, found 514.1389.
N-(1-Benzyl-1′-formyl-3′-(naphthalen-1-yl)-2,5′-dioxospiro-
[indoline-3,2′-pyrrolidin]-4′-yl)benzamide (5t). White solid (78.9 mg,
93% yield), >99:1:0:0 dr; mp 305.6−307.2 °C; 1H NMR (300 MHz,
DMSO-d6) δ 4.39 (d, J = 16.2 Hz, 1H), 4.63 (d, J = 16.2 Hz, 1H), 5.45
(d, J = 12.9 Hz, 1H), 6.18−6.25 (m, 2H), 6.77 (d, J = 7.2 Hz, 2H),
6.92−7.01 (m, 4H), 7.06−7.11 (m, 1H), 7.18−7.23 (m, 1H), 7.38−
7.53 (m, 6H), 7.65 (d, J = 8.1 Hz, 1H), 7.77−7.90 (m, 4H), 8.06 (d, J
= 8.4 Hz, 1H), 9.18 (s, 1H), 9.25 (d, J = 8.1 Hz, 1H); 13C NMR (75
MHz, DMSO-d6) δ 43.1, 46.0, 54.2, 65.9, 109.3, 122.4, 122.6, 124.4,
124.5, 126.5, 126.6, 127.1, 127.3, 127.6, 128.3, 128.4, 128.5, 128.8,
132.4, 132.8, 133.1, 135.1, 142.1, 159.4, 166.3, 172.7, 173.4; IR (KBr)
v 3357, 3067, 2924, 1768, 1720, 1698, 1668, 1615, 1538, 1490, 1468,
1334, 1315, 1298, 780, 757, 715 cm−1; HRMS (ESI-TOF) calcd for
C36H27N3NaO4 [M + Na]
+ 588.1894, found 588.1900.
N-(1-Benzyl-1′-formyl-2,5′-dioxo-3′-phenylspiro[indoline-3,2′-
pyrrolidin]-4′-yl)-4-bromobenzamide (5u). White solid (73.1 mg,
82% yield), >99:1:0:0 dr; mp 286.8−288.3 °C; 1H NMR (300 MHz,
DMSO-d6) δ 4.39 (d, J = 13.2 Hz, 1H), 4.85 (d, J = 15.9 Hz, 1H), 4.95
(d, J = 15.9 Hz, 1H), 6.00 (dd, J = 8.4 Hz, 12.9 Hz, 1H), 6.62 (d, J =
7.8 Hz, 1H), 6.92−7.09 (m, 7H), 7.26−7.32 (m, 5H), 7.69−7.81 (m,
5H), 9.12 (s, 1H), 9.34 (d, J = 8.1 Hz, 1H); 13C NMR (75 MHz,
DMSO-d6) δ 43.4, 52.1, 52.7, 65.8, 109.3, 122.5, 124.0, 124.9, 125.9,
127.4, 127.5, 128.0, 128.1, 128.3, 128.5, 129.5, 129.7, 131.5, 131.7,
132.0, 135.6, 142.4, 159.3, 165.4, 172.5, 172.9; IR (KBr) v 3367, 3056,
2924, 1769, 1718, 1706, 1658, 1615, 1528, 1485, 1467, 1335, 1315,
1301, 1012, 751, 727, 697 cm−1; HRMS (ESI-TOF) calcd for
C32H24BrN3NaO4 [M + Na]
+ 616.0842, found 616.0860.
Procedure for the Catalytic Asymmetric Reaction of 3-
Aminooxindole 4c and (Z)-Oleﬁnic Azlactone 2a. In an ordinary
vial equipped with a magnetic stirring bar, a solution of 4c (0.10
mmol), 2a (0.12 mmol), and catalyst A (5 mg, 10 mol %, 0.01 mmol)
in 3 mL of xylene was stirred at room temperature for 9 days. Then the
reaction mixture was directly puriﬁed by ﬂash chromatography
(petroleum ether/ethyl acetate = 10/1−2/1) on silica gel to yield
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chiral product 5c (23.6 mg, 47% yield) as a white solid with >99:1 dr
and 61% ee. [α]D
20 = +2.5 (c 0.50, CHCl3); the ee was determined by
HPLC (Chiralpak OD-H, i-PrOH/hexane = 20/80, ﬂow rate = 1.0
mL/min, λ = 254 nm, tminor = 8.0 min, tmajor = 7.2 min); the
1H NMR




a solution of compound 5m (0.11 mmol, 59 mg) in CH2Cl2 (12 mL)
were successively added 10% NaOH(aq) (11 mL) and TBAB (3.5 mg,
0.011 mmol). The resulting mixture was stirred at the room
temperature for 5 h. After completion of the reaction as indicated
by TLC, the mixture was extracted with CH2Cl2, and the combined
organic layers were dried over anhydrous Na2SO4 and concentrated.
The residue was puriﬁed by ﬂash chromatography on silica gel
(petroleum ether/ethyl acetate = 2/1) to yield product 6 as a white
solid (31.0 mg, 56% yield, >99:1:0:0 dr). Mp 301.2−302.7 °C; 1H
NMR (300 MHz, DMSO-d6) δ 3.59 (s, 3H), 4.31 (d, J = 12.6 Hz,
1H), 5.80 (dd, J = 9.0 Hz, 12.6 Hz, 1H), 6.48 (d, J = 7.5 Hz, 1H), 6.69
(d, J = 8.7 Hz, 2H), 7.00 (d, J = 8.7 Hz, 2H), 7.05−7.15 (m, 2H), 7.27
(d, J = 7.5 Hz, 2H), 7.42−7.55 (m, 5H), 7.59−7.64 (m, 2H), 7.88 (d, J
= 7.2 Hz, 2H), 8.76 (s, 1H), 9.02 (d, J = 9.0 Hz, 1H); 13C NMR (75
MHz, DMSO-d6) δ 51.1, 54.8, 55.0, 65.5, 109.1, 113.5, 123.3, 125.0,
125.3, 126.4, 127.4, 127.6, 128.4, 128.5, 129.0, 129.5, 130.0, 131.7,
133.4, 133.9, 142.3, 158.5, 166.3, 173.2, 174.8; IR (KBr) v 3359, 3061,
2928, 1731, 1705, 1659, 1614, 1543, 1515, 1500, 1466, 1254, 1033,
750, 700 cm−1; HRMS (ESI-TOF) calcd for C31H25N3NaO4 [M +
Na]+ 526.1737, found 526.1747.
Competition Experiment with 1a and 4a. In an ordinary vial
equipped with a magnetic stirring bar, 1a (0.1 mmol, 1.0 equiv), 4a
(0.1 mmol, 1.0 equiv), 2g (0.1 mmol, 1.0 equiv), and catalyst (DBU,
20 mol %) were dissolved in 10 mL of CH2Cl2, and then the mixture
was reﬂuxed for 8 h under an Ar atmosphere. After completion of the
reaction as indicated by TLC, the solvent was removed in vacuo, and




Copies of 1H and 13C NMR spectra for the products and single-
crystal X-ray crystallography data for 3m and 5b. This material
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